Pietropaolo M

Sep 2019

Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes.

Diabetes
Acevedo-Calado MJ, Pietropaolo SL, Morran MP, Schnell S, Vonberg AD, Verge CF, Gianani R, Becker DJ, Huang S, Greenbaum CJ, Yu L, Davidson HW, Michels AW, Rich SS, Pietropaolo M, Type 1 Diabetes TrialNet Study Group.
Jun 2018

Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.

Diabetes
James EA, Pietropaolo M, Mamula MJ
Apr 2017

Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development.

Diabetes Care
Acevedo-Calado M, James EA, Morran MP, Pietropaolo SL, Ouyang Q, Arribas-Layton D, Songini M, Liguori M, Casu A, Auchus RJ, Huang S, Yu L, Michels A, Gianani R, Pietropaolo M
May 2011

Investigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction.

PLoS One
Khadra A, Pietropaolo M, Nepom GT, Sherman A
Mar 2023

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.

Diabetes Care
Wilson DM, Pietropaolo SL, Acevedo-Calado M, Huang S, Anyaiwe D, Scheinker D, Steck AK, Vasudevan MM, McKay SV, Sherr JL, Herold KC, Dunne JL, Greenbaum CJ, Lord SM, Haller MJ, Schatz DA, Atkinson MA, Nelson PW, Pietropaolo M, Type 1 Diabetes TrialNet Study Group